26339-90-2

Basic information

• Product Name: AESCIN IB(SH)
• Synonyms: AESCIN IB(SH);beta-d-Glucopyranosiduronic acid, [3beta,16alpha,21beta(Z),22alpha]-22-(acetyloxy)-16,24,28-trihydroxy-21-[(2-methyl-1-oxo-2-butenyl)oxy]olean-12-en-3-yl O-beta-d-glucopyranosyl-(1->2)-O-[beta-d-glucopyranosyl-(1->4)]-;Escin IB(Aescin IB);22α-(Acetyloxy)-16α,24,28-trihydroxy-21β-[[(Z)-2-methyl-1-oxo-2-butenyl]oxy]oleana-12-ene-3β-yl 4-O-[2-O-(β-D-gluco-hexopyranosyl)-β-D-gluco-hexopyranosyl]-β-D-gluco-hexopyranosiduronic acid;β-d-Glucopyranosiduronic acid, [3β,16α,21β(Z),22α]-22-(acetyloxy)-16,24,28-trihydroxy-21-[(2-methyl-1-oxo-2-butenyl)oxy]olean-12-en-3-yl O-β-d-glucopyranosyl-(1→2)-O-[β-d-glucopyranosyl-(1→4)]-;Escin Ib;Aescin IB;Aescin B
• CAS NO: 26339-90-2
• Molecular Formula: C55H86O24
• Molecular Weight: 1131.26
• EINECS: 247-619-4
• Product Categories: chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract
• Mol File: 26339-90-2.mol
• Article Data: 0

Chemical Properties

• Melting Point: 224～227℃
• Boiling Point: 1140.6 °C at 760 mmHg
• Flash Point: 311.8 °C
• Appearance: /
• Density: 1.46 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.627
• PKA: 2.63±0.70(Predicted)
• CAS DataBase Reference: AESCIN IB(SH)(CAS DataBase Reference)
• NIST Chemistry Reference: AESCIN IB(SH)(26339-90-2)
• EPA Substance Registry System: AESCIN IB(SH)(26339-90-2)

Safety Data

• Hazardous Substances Data: 26339-90-2(Hazardous Substances Data)

Usage

General Description

AESCIN IB(SH) is a chemical compound that belongs to the group of saponins, also known as escin. It is commonly found in horse chestnut seeds and has been used in traditional medicine for its anti-inflammatory and venotonic properties. AESCIN IB(SH) has been reported to have potential therapeutic effects in conditions such as chronic venous insufficiency, hemorrhoids, and edema. It is known for its ability to strengthen blood vessel walls and reduce capillary permeability, which makes it useful in treating various circulatory disorders. Additionally, AESCIN IB(SH) has been studied for its potential antioxidant and neuroprotective effects. Overall, AESCIN IB(SH) is a compound with promising medicinal properties and has shown potential in various therapeutic applications.

InChI:InChI=1/C55H86O24/c1-10-23(2)46(71)79-43-44(72-24(3)60)55(22-59)26(17-50(43,4)5)25-11-12-30-51(6)15-14-32(52(7,21-58)29(51)13-16-53(30,8)54(25,9)18-31(55)61)75-49-41(77-48-38(67)36(65)34(63)28(20-57)74-48)39(68)40(42(78-49)45(69)70)76-47-37(66)35(64)33(62)27(19-56)73-47/h10-11,26-44,47-49,56-59,61-68H,12-22H2,1-9H3,(H,69,70)/b23-10-/t26-,27+,28+,29+,30+,31+,32-,33+,34+,35-,36-,37+,38+,39-,40-,41+,42-,43-,44-,47-,48-,49+,51-,52+,53+,54+,55-/m0/s1